Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA AUROBINDO PHARMA GRANULES INDIA/
AUROBINDO PHARMA
 
P/E (TTM) x 26.4 23.0 114.7% View Chart
P/BV x 3.7 2.4 155.5% View Chart
Dividend Yield % 0.3 0.3 126.7%  

Financials

 GRANULES INDIA   AUROBINDO PHARMA
EQUITY SHARE DATA
    GRANULES INDIA
Mar-23
AUROBINDO PHARMA
Mar-23
GRANULES INDIA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs381715 53.4%   
Low Rs227397 57.1%   
Sales per share (Unadj.) Rs186.4424.2 43.9%  
Earnings per share (Unadj.) Rs21.332.9 64.9%  
Cash flow per share (Unadj.) Rs29.054.1 53.5%  
Dividends per share (Unadj.) Rs1.503.00 50.0%  
Avg Dividend yield %0.50.5 91.4%  
Book value per share (Unadj.) Rs116.4458.1 25.4%  
Shares outstanding (eoy) m242.04585.94 41.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.61.3 124.5%   
Avg P/E ratio x14.216.9 84.3%  
P/CF ratio (eoy) x10.510.3 102.2%  
Price / Book Value ratio x2.61.2 215.3%  
Dividend payout %7.09.1 77.1%   
Avg Mkt Cap Rs m73,611325,753 22.6%   
No. of employees `000NANA-   
Total wages/salary Rs m4,20335,223 11.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m45,119248,554 18.2%  
Other income Rs m1432,906 4.9%   
Total revenues Rs m45,262251,460 18.0%   
Gross profit Rs m9,13337,070 24.6%  
Depreciation Rs m1,84512,446 14.8%   
Interest Rs m5591,405 39.8%   
Profit before tax Rs m6,87226,125 26.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,7066,849 24.9%   
Profit after tax Rs m5,16619,277 26.8%  
Gross profit margin %20.214.9 135.7%  
Effective tax rate %24.826.2 94.7%   
Net profit margin %11.47.8 147.6%  
BALANCE SHEET DATA
Current assets Rs m25,741214,599 12.0%   
Current liabilities Rs m18,135114,938 15.8%   
Net working cap to sales %16.940.1 42.0%  
Current ratio x1.41.9 76.0%  
Inventory Days Days1421 70.1%  
Debtors Days Days7766 117.0%  
Net fixed assets Rs m23,290176,668 13.2%   
Share capital Rs m242586 41.3%   
"Free" reserves Rs m27,927267,813 10.4%   
Net worth Rs m28,169268,399 10.5%   
Long term debt Rs m1,4866,190 24.0%   
Total assets Rs m49,031392,125 12.5%  
Interest coverage x13.319.6 67.8%   
Debt to equity ratio x0.10 228.8%  
Sales to assets ratio x0.90.6 145.2%   
Return on assets %11.75.3 221.4%  
Return on equity %18.37.2 255.3%  
Return on capital %25.110.0 249.9%  
Exports to sales %81.033.7 240.4%   
Imports to sales %31.315.3 204.4%   
Exports (fob) Rs m36,52683,703 43.6%   
Imports (cif) Rs m14,12038,060 37.1%   
Fx inflow Rs m36,52685,483 42.7%   
Fx outflow Rs m14,12041,447 34.1%   
Net fx Rs m22,40644,036 50.9%   
CASH FLOW
From Operations Rs m7,38723,868 31.0%  
From Investments Rs m-1,914-39,778 4.8%  
From Financial Activity Rs m-4,40318,144 -24.3%  
Net Cashflow Rs m1,0682,298 46.5%  

Share Holding

Indian Promoters % 41.6 48.8 85.3%  
Foreign collaborators % 0.4 3.1 11.4%  
Indian inst/Mut Fund % 28.9 41.3 70.0%  
FIIs % 18.8 20.7 90.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 48.2 120.5%  
Shareholders   190,691 241,944 78.8%  
Pledged promoter(s) holding % 4.1 20.1 20.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GRANULES INDIA vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GRANULES INDIA vs Aurobindo Pharma Share Price Performance

Period GRANULES INDIA Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 0.03% 1.82% 1.18%
1-Month -6.51% 5.96% -0.75%
1-Year 58.65% 113.07% 61.82%
3-Year CAGR 11.62% 7.78% 18.16%
5-Year CAGR 29.84% 7.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the GRANULES INDIA share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of GRANULES INDIA hold a 42.0% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GRANULES INDIA and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, GRANULES INDIA paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 7.0%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of GRANULES INDIA, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.